Measurement of Warfarin in the Oral Fluid of Patients Undergoing Anticoagulant Oral Therapy

Background: Patients on warfarin therapy undergo invasive and expensive checks for the coagulability of their blood. No
information on coagulation levels is currently available between two controls.
Methodology: A method was developed to determine warfarin in oral fluid by HPLC and fluorimetric detection. The
chromatographic separation was performed at room temperature on a C-18 reversed-phase column, 65% PBS and 35%
methanol mobile phase, flow rate 0.7 mL/min, injection volume 25 mL, excitation wavelength 310 nm, emission wavelength
400 nm.
Findings: The method was free from interference and matrix effect, linear in the range 0.2-100 ng/mL, with a detection
limit of 0.2 ng/mL. Its coefficient of variation was ,3% for intra-day measurements and ,5% for inter-day measurements.
The average concentration of warfarin in the oral fluid of 50 patients was 2.561.6 ng/mL (range 0.8-7.6 ng/mL). Dosage
was not correlated to INR (r =20.03, p = 0.85) but positively correlated to warfarin concentration in the oral fluid (r = 0.39,
p = 0.006). The correlation between warfarin concentration and pH in the oral fluid (r = 0.37, p = 0.009) confirmed the
importance of pH in regulating the drug transfer from blood. A correlation between warfarin concentration in the oral fluid
and INR was only found in samples with pH values $7.2 (r = 0.84, p = 0.004).
Conclusions: Warfarin diffuses from blood to oral fluid. The method allows to measure its concentration in this matrix and
to analyze correlations with INR and other parameters.